StreetAlpha.app
Home › Stocks › HIMS

Hims & Hers Health, Inc. (HIMS)

Consumer Defensive
$17.55
▼ −5.44%
LAST CLOSE · NOV 17

Hims & Hers is a telehealth company that connects consumers with licensed providers for prescriptions and health products. It last closed at $17.55 on Nov 17, down 5.44% on the day. HIMS last reported earnings on Mon, Nov 9, 2026. The average 12-month price target from 7 analysts is $29.57 (+68.5% from the last close), with a high of $35.00 and a low of $24.00. Analyst consensus is Hold, based on the latest ratings from 7 firms (2 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in HIMS, 43% of them bullish and 57% bearish. In the past 30 days there were 3 dark pool prints totaling $3.1M, the largest $1.2M.

AI Auto Pilots
Is HIMS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.9B
+29.8% vs a year ago
Net income
−$190.8M
−242.6% vs a year ago
EPS (diluted)
−$0.83
−256.6% vs a year ago
Free cash flow
$8.2M
0.3% margin
Balance sheet
Cash & equivalents
$605.6M
At Sep 30
Shareholder equity
$355.3M
Buybacks
$80.5M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $271.9M$271.9MFY2021FY2022: $526.9M$526.9MFY2022FY2023: $872.0M$872.0MFY2023FY2024: $1.5B$1.5BFY2024FY2025: $2.3B$2.3BFY2025

From HIMS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Nov 9
2026 · After the close (AMC)
Reported EPS
$0.03
vs $0.07 est. · miss
Year-ago EPS
—
Not on file
Options-implied move
±12.4%
Priced in before that report
Analyst consensus
Hold
Based on 7 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
7firms
2 Buy5 Hold0 Sell
Each firm's latest rating on HIMS in the past 90 days
Average 12-month target
$29.57
▲ 68.5% upside

Based on 7 analysts who set a price target on HIMS in the past 90 days. The average target is $29.57, with a high of $35.00 and a low of $24.00, compared with the last close of $17.55.

$16$24$32$40PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $35AVG $29.57LOW $24May 22LAST CLOSE+12 MO$16$24$32$40PAST 112 DAYSTARGETSHIGH $35AVG $29.57LOW $24May 22LAST CLOSE+12 MO
Highest target$35.00
Average target$29.57
Lowest target$24.00
Latest rating changes
JefferiesMaintained
Nov 10Hold$24
Morgan StanleyTarget lowered
Nov 10Hold$28 → $25
Evercore ISI GroupMaintained
Nov 10Hold$27
NeedhamTarget lowered
Nov 10Buy$42 → $32
JP MorganAssumed coverage
Sep 11Hold$35 → $32
DateFirmActionRatingPrice target
Nov 10JefferiesMaintainedHold$24
Nov 10Morgan StanleyTarget loweredHold$28 → $25
Nov 10Evercore ISI GroupMaintainedHold$27
Nov 10NeedhamTarget loweredBuy$42 → $32
Sep 11JP MorganAssumed coverageHold$35 → $32
Loading…

Technical Analysis

HIMS · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 41% below its 20 day and 55% below its 50 day average. It is 52% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 30), oversold. The nearest support is the Pivot S1 at $16.89, and the nearest resistance the Pivot at $17.80.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 11.6%/day
Key levels
$40.9952 week high+133.6%
$29.44Swing high (Sep 14)+67.7%
$29.35100 day average+67.2%
$27.2150 day average+55.0%
$26.59200 day average+51.5%
$24.7220 day average+40.9%
$18.45Pivot R1+5.1%
$17.80Pivot+1.4%
$17.55Last close
$16.89Pivot S1−3.8%
$13.7452 week low−21.7%
Indicators
RSI (14)29.54Oversold below 30Oversold
MACD-2.67Below its signal lineBearish
Stochastic5.3Near the bottom of its rangeOversold
ADX (14)28.0Trending down
Williams %R-96.8Oversold below −80, overbought above −20Oversold
CCI (20)-137.5Oversold below −100, overbought above 100Oversold
Rate of change−31.7%Change over 10 sessionsBearish
ATR (14)$2.04Typical daily range, 11.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for HIMS

What happened before

See how HIMS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow is mixed3 bullish and 4 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow HIMS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How HIMS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
7
Bullish
3
43%
Bearish
4
57%
Date span
Aug 25 – Oct 28
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$3.1M
Largest print
$1.2M
Loading…

HIMS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●227 buying vs 250 selling
  • ●Shares held by funds +0.2%
  • ▼Funds holding -37
  • ▲Superinvestors: 2 added, 1 cut
  • ▲Put/call 0.95 to 0.69
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding475512−7.2%
In funds' top 1089−11.1%
Held by funds–––
New / increased62 / 165141 / 179−29.1%
Reduced / sold out163 / 87129 / 66+28.2%
Put/call ratio0.690.95−27.5%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HIMS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HIMS is in one of them and how their past HIMS trades turned out.

HIMS in the AI portfolios
Loading…

HIMS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HIMS in an article yet. Here's the latest on the wider market.

HIMS Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Jan 9
Who traded HIMS · since 2025
Latest 2 filings
$100K – $250KTraded Dec 17, 2025Filed Jan 9, 2026
$1K – $15KTraded Aug 4, 2025Filed Sep 12, 2025
PersonTypeAmountTradedFiledDelay
Tony WiedR · WISell$100K – $250KDec 17, 2025Jan 9, 202623 d
Lisa McClainR · MIBuy$1K – $15KAug 4, 2025Sep 12, 202539 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Hims & Hers Health

Hims & Hers is a telehealth company based in San Francisco, California. It connects patients with licensed healthcare professionals who can prescribe medications for conditions such as hair loss, sexual health, weight loss, dermatology and mental health, with prescriptions filled through pharmacies it operates and other licensed pharmacies. The company also sells nonprescription health, wellness, skincare and supplement products, along with laboratory testing, many on a subscription basis. Its customers are consumers in the United States, Canada, the United Kingdom and parts of Europe.

Headquarters
San Francisco, CA
Founded
2017